Myopathy is a common complication of severe burn patients. One potential cause of this myopathy could be failure of the plasma membrane to undergo repair following injuries generated from toxin or exercise. The aim of this study is to assess systemic effect on muscle membrane repair deficiency in burn injury. Skeletal muscle fibers isolated from burn-injured mice were damaged with a UV laser and dye influx imaged confocally to evaluate membrane repair capacity. Membrane repair failure was also tested in burn-injured mice subjected to myotoxin or treadmill exercise. We further used C2C12 myotubules and animal models to investigate the role of MG53 in development of burn-induced membrane repair defect. We demonstrated that skeletal muscle myofibers in burn-injured mice showed significantly more dye uptake after laser damage than controls, indicating a membrane repair deficiency. Myotoxin or treadmill exercise also resulted in a higher-grade repair defect in burn-injured mice. Furthermore, we observed that burn injury induced a significant decrease in MG53 levels and its dimerization in skeletal muscles. Our findings highlight a new mechanism that implicates membrane repair failure as an underlying cause of burn-induced myopathy. And, the disorders in MG53 expression and MG53 dimerization are involved in this cellular pathology.
Severe burns continue to be a major medical problem globally, with significant mortality and disability resulting from a devastating impairment perturbing nearly every organ system 1, 2 . It has been established that burn injury increases the possibility of development of systemic myopathy characterized by muscle wasting, muscle weakness, and altered bioenergetics. These acquired myopathic derangements result in difficulty in weaning off the ventilator, prolonged mechanical ventilation, pulmonary infection, exercise limitation, metabolic disorders, and poor quality of life [3] [4] [5] . The mechanisms leading to these muscular changes are linked to the high-grade of inflammatory factors in plasma, and activation of proteolytic pathways in skeletal muscles 6, 7 . However, abundant evidence indicates that the mechanisms responsible for myopathy in burn patients could be complex and multifactorial 8, 9 . To our knowledge, skeletal muscle membrane integrity is commonly recognized as a main factor in the pathogenesis of myopathy 10 . Not unexpectedly, the myocyte membranes have been shown to be injured by thermal force at the site of burn. However, the changes of integrity in sarcolemmal membrane distant from the site of burn injury remain unclear.
Plasma membrane injuries are naturally appearing in mechanically active organs, such as cardiac and skeletal muscle. Skeletal muscle contractions, especially high-force eccentric exercise, disrupt the myocyte membranes of the contracting myofibers. However, these disruptions are transient and rarely fatal injuries because they can trigger in the injured myofibers a rapid membrane repair response which is initiated by the influx of extracellular molecules 11 . Briefly, the influx of extracellular molecules initiates fusion of internal plasma membrane, thus forming a "patch vesicle", which is then accurately transported to the injured site to reform myocyte membrane 12 .
During the life cycle of skeletal muscle, membrane repair response is a fundamental process in maintaining membrane continuity, as demonstrated by recent studies that link defective membrane repair to the progression of muscle membrane injury 10 . Reportedly, many proteins are essential for the diverse fusion events of membrane repair response. Thus, almost all muscle diseases induced by membrane repair failure are demonstrated to be associated with these proteins 11 . MG53 belongs to the Tripartite motif (TRIM) family of proteins and is one of the several membrane proteins that participate in the membrane repair response 13, 14 . These skeletal muscles lacking MG53 display increased Scientific RepoRts | 6:31409 | DOI: 10.1038/srep31409 membrane permeability, which ultimately result in serious myopathy 15, 16 . It has been reported that MG53 is transcriptionally activated by IRS-1/PI3K/Akt signal pathway in skeletal muscle fibers 17 . However, this signal pathway is always inhibited in skeletal muscles for prolonged periods of time after burn injury 18 . Consequently, there is a possibility that skeletal muscle membrane in burn injury would be fragile because of MG53 deficiency.
Here, we hypothesized that sustained musculoskeletal abnormalities that occur in burn patients are caused by on-going membrane injury. As a test of this hypothesis, we extracted skeletal muscles distant from the site of burn injury, and assessed systemic effect on musculoskeletal membrane integrity and musculoskeletal membrane repair deficiency in burn injury using various methodologies. We further used an in vivo and in vitro model of burn injury to investigate the underlying molecular mechanisms associated with defective membrane repair in burn-injured mice.
Results
In vivo analysis of muscle membrane integrity after burn in mice. To determine whether myocytes membrane integrity is affected in distant muscles as a result of burn injury, we monitored gastrocnemius muscle myofibers permeability by exploiting Evans Blue dye (EBD). Mice were intraperitoneally or intramuscularly injected with this dye to identify injured and "leaky" myofibers membrane. Gastrocnemius muscle sections from burn-injured mice displayed significantly more areas of EBD staining when compared with sham-injured mice (Fig. 1a,b) . Quantitative analysis of total EBD within extracted gastrocnemius muscle bundles provided direct validation to the above results and displayed a significant increase in dye after burn injury (Table 1) . Taken together, these results reveal the presence of musculoskeletal membrane damage in a distant muscle as a result of burn injury. In vivo/ex-vivo analysis of muscle membrane repair after burn in mice. To test if myocytes membrane injury is exacerbated in burn-injured mice during eccentric contraction, our study measured gastrocnemius muscle myofibers permeability by EBD in mice subjected to treadmill exercise 11, 19, 20 . Compared with non-exercised controls, sham-injured mice demonstrated no significant changes in EBD staining after downhill running (Fig. 2a,b) . In contrast, burn-injured mice showed significantly more EBD staining after downhill running, when compared with non-exercised controls (Fig. 2a,b) . These findings were supported by quantitative analysis of total EBD within extracted gastrocnemius muscle bundles ( Table 1) . We next injected myotoxin from Naja mossambica (CTX) 19 , a toxin that injures myofibers membrane, into the gastrocnemius muscles. At 12 hours post-injection, the serum LDH and CK-MB levels in burn-injured mice significantly increased and provided an effective marker of the disruptions of myocytes membrane (Fig. 2c,d ).
To directly evaluate musculoskeletal membrane repair efficiency of burn-injured mice, we subjected flexor digitorum brevis (FDB) myofibers isolated from burn-injured and sham mice to laser-induced injury and monitored membrane permeability via FM1-43 fluorescent dye entry 20 . FM1-43 strongly and selectively stains the plasma membrane of intact myocytes, however, this pattern can be disrupted with laser damage, which causes membrane disruption and diffusion of the dye to the cytosol. We demonstrated that normal myofibers from sham-injury mice could rapidly and effectively reform injured membrane, as they only showed minimal FM1-43 dye influx after ultraviolet laser damage (Fig. 3) . In contrast, we observed more FM1-43 fluorescent dye entry in myofibers from burn-injured mice after laser-induced damage (Fig. 3) .
Thus, both in vivo and ex-vivo model systems strongly support our hypothesis that muscle membrane repair fails in a distant muscle as a result of burn injury.
Effects of burn injury on MG53 expression and dimerization. To investigate whether there was a causal relationship between MG53 and burn-induced sarcolemmal membrane damage, we first assessed endogenous MG53 protein levels in gastrocnemius muscle by western blot and immunohistochemistry analysis. Western blot analysis illustrated the statistically significant decline in MG53 expression in gastrocnemius muscle at 10 and 14 d after burn injury (Fig. 4a) . Immunohistochemistry analysis validated that the MG53 protein is mainly localized to the myocytes membrane and this staining pattern is significantly decreased after burn injury when compared with sham controls (Fig. 4b) . Furthermore, Western blot analysis (in the absence of DTT) showed that burn injury induced a significant decline in MG53 dimer in muscles at 5, 10 and 14 d after burn injury, compared with sham injury control (Fig. 4c) .
Protein disulfide isomerase (PDI) inactivation disrupts MG53 dimerization. PDI can catalyze the formation and breakage of disulfide bonds between cysteine residues within many proteins. Lacking functional PDI can increase cellular protein misfolding and thus result in a serious perturbation in dimerization of these proteins 21 . To determine whether the process in MG53 dimerization is affected by PDI, we detected MG53 dimer in C2C12 myotubules after inhibiting PDI activity with 16F16 and thiomuscimol 22 . As illustrated in Fig. 5a ,b, inhibition of PDI resulted in a significant decline in MG53 dimer levels in C2C12 myotubules, while showed no significant changes in MG53 protein levels. Furthermore, PDI activity was demonstrated to be reduced in gastrocnemius muscle at 5, 10 and 14 d after burn injury (Fig. 5c ), indicating that PDI inactivation could be a possible cause of MG53 dysfunction in burn injury.
Reportedly, NO mediated S-nitrosylation of PDI (SNO-PDI) can inhibit PDI activity and the beneficial effects of PDI 23 . In this study, the NO levels were significantly increased in gastrocnemius muscle after burn injury (Fig. 5d) . We further demonstrated that the SNO-PDI levels were significantly increased in gastrocnemius muscle after burn injury (Fig. 5e) .
Moreover, it has been established that PDI can be oxidized and lose its activity in presence of endoplasmic reticulum stress (ERS) 24 In this study, we illustrated that CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP), a major ERS marker, was significantly increased in gastrocnemius muscle at 5, 10 and 14 d after burn injury (Fig. 5e ). Fig. 6a ,b, insulin could upregulate MG53 mRNA and protein levels in C2C12 myotubules when compared with controls, and that these effects could be abolished by inhibition of PI3K via LY294002. These results validate the notion that MG53 expression is regulated by IRS-1/PI3K signal pathway 17 . In this study, burned mice showed that IRS-1 expression in muscles began to decrease at 2 d after burn injury and that this decline remained up to 14 d after the injury, when compared with sham controls (Fig. 7a) . The in vitro studies also showed that burn serum induced a significant decline in IRS-1 protein levels in myotubules when compared with the controls (Fig. 7b,c) . Insulin insensitivity induced by Suppressor of cytokine signaling (SOCS). It has been established that SOCS-1 and SOCS-3 are transcriptionally regulated by JAK/STAT signal pathway, and have been shown to block IRS-1/PI3K/Akt signal pathway. To investigate the roles of SOCS-1 and SOCS-3 in insulin insensitivity after burn injury, we demonstrated that both SOCS-1 and SOCS-3 were significantly increased Figure 2 . In vivo analysis of sarcolemmal membrane repair capacity after burn injury in mice. (a) EBD was intramuscularly injected into the mice subjected to treadmill exercise. Myofibers that failed to repair membrane in gastrocnemius muscles from sham injury (C) and burn injury (B) in mice are labeled. The number of EBDpositive myofibers counted from these micrographs. *P < 0.05; n = 5 (Scale bar, 500 μm; 200 μm). (b) EBD was intraperitoneally injected into mice subjected to treadmill exercise. Myofibers that failed to repair membrane in gastrocnemius muscles from sham injury (C) and burn injury (B) in mice are labeled. The number of EBDpositive myofibers counted from these micrographs. *P < 0.05; n = 5 (Scale bar, 500 μm; 200 μm). (d) CTX was intramuscularly injected into mice. Mice serum was collected for ELISA tests for the levels of LDH. *P < 0.05; n = 3. (e) CTX was intramuscularly injected into mice. Mice serum was collected for ELISA tests for the levels of CK-MB. *P < 0.05; n = 3.
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in gastrocnemius muscles two weeks after burn injury (Fig. 7a) . The in vitro studies also illustrated that burn serum increased the expression of both SOCS-1 and SOCS-3 proteins when compared with control Figure 3 . In ex-vivo analysis of membrane repair capacity after burn injury in mice. Healthy FDB fibers isolated from sham injury (C) mice exclude FM1-43 dye after laser induced injury, whereas fibers from burn injury (B) mice results in sustained filling of the entire fiber with dye, indicating a membrane repair defect. Arrow indicates damaged site at 300 s after laser injury. An area of about 200 μm adjacent to the injury site was utilized for measuring FM1-43 dye influx fluorescent intensity. Data is presented as ΔF/F 0 . *P < 0.05 vs. Control; n = 3 (Scale bar, 100 μm).
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myotubules cultured with sham serum (Fig. 7b,c) . Moreover, we demonstrated that the burn serum-induced increase in SOCS-1 and SOCS-3 protein levels both returned to control values by inhibition of STAT with S3I-201, while IRS-1 began to increase significantly (Fig. 7d) . 
Discussion
Musculoskeletal derangements, a well-known medical complication of burn patients, include muscle atrophy, muscle weakness and bioenergetic disorders, markedly contributing to the incidence of mortality and disability in burn patients 1, 25 . This acquired systemic skeletal muscle myopathy, generally speaking, has been viewed as a result of muscles proteolysis causing by systemic inflammatory response syndrome (SIRS) 5 . However, the proteolytic pathways in skeletal muscles display persistent activation after burn injury, even when inflammatory factors in plasma are significantly decreased. Recently, abundant evidence indicates that sarcolemmal membrane injury is a major factor in the development of many myopathies 11, 26, 27 . However, the roles of sarcolemmal membrane damage in myopathy in burns remain unknown. A striking observation of our study was that burn injury induced a serious failure of plasma membrane repair, resulting in skeletal muscle membrane injury.
In this study, myofibers isolated from burn-injured mice displayed a significant increase in EBD staining via morphological and quantitative analyses, indicating that burn injury exacerbated skeletal muscle membrane injury. How could severe burns result in myofiber membranes damage? Membrane repair response is such a crucial process to repair the membrane of the injured myotubes in a timely and accurate manner that membrane damages are transient and rarely cause fatal injuries. In ex-vivo, we found that skeletal muscle myofibers from burn-injured mice displayed a disability to repair membrane disruptions following laser damage. In vivo, we used EBD to show that repair of damages, induced by treadmill exercise, is impaired in burn-injured mice, indicating that the membrane repair defect is not one unique to a UV laser injury, but one that arises under physiological conditions as well. Furthermore, compared with sham controls, the serum LDH and CK-MB levels in burn injury significantly increased after intramuscular injection of CTX, which also provided an effective marker of the skeletal muscle membrane repair defects in burn injury. Therefore, these findings in vivo and ex-vivo models suggest burn injury led to a significant failure of plasma membrane repair in skeletal muscle, which could be a major pathogenesis of burn-induced musculoskeletal membrane injury.
It is convinced that continuous release of intracellular "danger" signals or myokines from myocytes with defective membrane repair induces localized inflammation and exerts autocrine, paracrine and endocrine effects within the muscle itself as well as other organs to aggravate muscular bioenergetic dysfunctions, then resulting in muscle atrophy, muscle weakness, thus leading to myopathy 10, 28 . Indeed, multiple forms of muscular diseases are caused by sarcolemmal membrane repair failure, such as DMD and diabetic myopathy. Interestingly, severe burns also induce a significant reduction of muscle mass, capacity, and bioenergetic dysfunctions, and these muscular changes in burn patients are similar to that showed in DMD and diabetic myopathy 11, 27 , indicating that membrane repair failure underlie the burn-induced skeletal muscle membrane damage, and ultimately result in myopathy.
How could burn injury result in membrane repair failure? Numerous proteins have been demonstrated to participate in sarcolemmal membrane repair response, one of which is MG53. There are abundant studies showing that MG53 plays a major role in sensing the influx of extracellular oxidants and facilitating "patch vesicles" translocation of membrane repair machinery to initiate this repair response 12, 15, 16, 29, 30 . It has been reported that the mice lacking functional MG53 result in the development of muscular atrophy 15, 19 . In particular, protein disulfide bond formation mediated by Cys242 is essential for MG53-mediated translocation of "patch vesicles" toward the disruption sites, as expression of cysteine mutation, C242A, results in nearly complete loss of MG53 dimerization and a significant failure of membrane repair 31 . Strikingly, MG53 dimer levels in skeletal muscles began to decrease at 5 d after burn injury, while MG53 expression showed no significant changes in these muscles at this time point. These results indicate that burn injury induces a perturbation in MG53 dimerization, which can be a key molecular mechanism leading to burn-induced musculoskeletal membrane repair failure.
To our knowledge, PDI has been demonstrated to participate in disulfide bonds formation between cysteine residues, and is essential for the dimerization of many proteins 32 . In this study, our in vitro findings showed MG53 dimer levels in myotubules were reduced by inhibition of PDI with 16F16 and thiomuscimol, indicating that PDI was an essential enzyme participating in the formation of disulfide bonds between MG53. Furthermore, we showed that the PDI activity in skeletal muscle was significantly decreased after burn injury. Therefore, these findings together indicate that burn-induced PDI inactivation, can inhibit MG53 dimerization, and finally, result in membrane repair failure. We further demonstrated that the NO levels in skeletal muscle significantly increased, and PDI was mediated by NO to produce a "SNO-PDI". This NO mediated S-nitrosylation of PDI could be a possible cause of PDI inactivation in burn injury 22, 23 . In addition, PDI can become oxidized and lose its ability to function as a disulphide bond-rearranging enzyme in the presence of ERS 24 . We demonstrated that CHOP, a major ERS marker, was significantly increased in skeletal muscles after burn injury, indicating that ERS also participated in burn-induced PDI inactivation.
In addition, we showed that the total MG53 content in skeletal muscle was reduced at the beginning of 10 d after burn injury. As a result, MG53-deficiency could be another molecular mechanism causing burn-induced sarcolemmal membrane repair defect 15 . In C2C12 myotubules, MG53 mRNA and protein levels could be elevated by insulin and abolished by PI3K inhibition using LY294002, indicating that burn-induced MG53-deficiency could be caused by insulin insensitivity. Indeed, skeletal muscle insulin insensitivity is a common phenomenon observed for prolonged periods of time after burn injury 18, [33] [34] [35] . Thus, we believe that this burn-induced chronic insulin insensitivity participates in sarcolemmal membrane repair deficiency via MG53.
It has been established that IRS-1 is a major protein to transport the signal from insulin and its deficiency has been observed to be a common primary cause of persistent insulin insensitivity 18 . In this study, we illustrated that burn injury induced a persistent decline in IRS-1 protein levels in skeletal muscles, which validated the notion that IRS-1 proteins are a main target for the development of chronic insulin insensitivity in burn injury. Meanwhile, we demonstrated that both SOCS-1 and SOCS-3 were significantly increased in skeletal muscles two weeks after burn injury. Further, in our in vitro model system, we observed that burn serum rapidly enhanced SOCS-1 and SOCS-3 expression, and subsequently decreased IRS-1 protein. However, these effects were shown to be abolished by inhibition of STAT with S3I-201. These findings in vivo and in vitro together suggest that a high-grade of inflammation is induced after burn injury and that SOCS-1 and SOCS-3 mediated ubiquitin pathways could be involved in degradation of IRS-1 after burn injury, which finally results in prolonged insulin insensitivity.
The fact that membrane repair failure is a major pathogenetic mechanism of burn-induced myopathy cannot be undermined. In our opinion, promotion of endogenous MG53 and MG53-dimerization is a novel measure to repair sarcolemmal membrane and prevent burn-induced myopathy. In addition, Weisleder and colleagues recently demonstrated that the mice treated with recombinant human MG53 (rhMG53) displayed decreased muscle membrane damage and reduced muscle pathology without toxicity 19 . These results suggest that treatment with recombinant human MG53 could improve muscle membrane damage in burn injuries.
In summary, we provide evidence from in vivo and ex-vivo assays that show that the burn injury induces a significant failure of musculoskeletal membrane repair, which leads to skeletal muscle membrane damage. It is conceivable that this membrane repair failure could negatively affect musculoskeletal functions in burn patients. Furthermore, our results have identified, for the first time that the disorders in MG53 expression and MG53 dimerization are involved in musculoskeletal membrane repair defects as a result of burn injury. However, the pathogenesis of myopathy in burn patients is thought to be complex and multifactorial, and therefore, trials on human subjects are warranted to confirm the findings of our study, and their application to humans.
Materials and Methods
Reagents. Antibodies to MG53, IRS-1, SOCS-1 and SOCS-3 were obtained from Abcam (Cambridge, MA, USA). Antibodies to PDI and CHOP were obtained from Cell Signal Technology (Danvers, MA, USA). Antibodies to Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were purchased from KangChen Shanghai (Shanghai, China). FM1-43 dye was obtained from Biotium (Hayward, CA). Biotin-HPDP was obtained from Thermo Fisher Scientific (Waltham, MA USA ), Pentobarbital, Buprenorphine and Lactated ringer's solutions were obtained from Chongqing pharmaceutical industry (Chongqing, China). LY294002 and S3I-201 were obtained from Beyotime Biotechnology (Shanghai, China). Tyrode solution (5 mM KCl, 140 mM NaCl, 2 mM MgCl2, 2.5 mM CaCl2 and 10 mM HEPES (pH 7.2)) were obtained from Shanghai Biotechnology (Shanghai, China). Unless marked, all reagents were obtained from Sigma-Aldrich (St,Louis, MO, USA).
Animal models. One hundred eight male BALB/C mice (6 weeks old, 25 g to 30 g body weight) were obtained from the Third Military Medical University Laboratory Animal Centre. The mice were raised in individual cages under 22-25 °C and with a 12 h light-dark cycle. The mice were used to the environment with a standard diet for a week prior to the experiment. One hundred eight mice were randomly divided into two groups, control (C) and burn-injury (B) groups. The mice from B group were subjected to 30% total body surface area (TBSA) of full thickness burn as previously described 36 . Briefly, mice were anesthetized with 1% pentobarbital (40 mg/kg of body weight), treated with buprenorphine (1 mg/kg body of weight) for analgesia and their backs were shaven with hair clippers. Mice were placed in a model designed to expose 30% of their dorsa skin to a hot water bath at 90 °C for 10 s. After injury, mice were intraperitoneally injected with lactated ringer's solution (50 ml/kg of body weight). Cell culture. Our C2C12 were obtained from ATCC (Manassas, VA, USA) and cultured by Dulbecco's modified Eagle's medium (DMEM) supplement with 10% fetal bovine serum (Gibco) and 1% penicillin/streptomycin in a 5% CO 2 incubator at 37 °C. Sequentially, confluent C2C12 myoblasts were differentiated for 48 h by incubation with DMEM supplemented with 2% horse serum. Membrane repair assay in vivo. (1) EBD (1%, 10 ml/kg of body weight, Sigma-Aldrich) was intraperitoneally and intramuscularly injected into burn-injured and sham control mice 12 h prior to exercise training. Mice were subsequently subjected to treadmill exercise (Zhenghua Instruments, AnHui, China) at 15 m/min for 90 min. Then, the mice were sacrificed by cervical dislocation and gastrocnemius muscles were intactly excised. Gastrocnemius muscles were sectioned and imaged on a Zeiss-LSM 510 confocal microscope. Furthermore, gastrocnemius muscles were soaked in formamide for 48 h at 55 °C in dark place. We next used the spectronic 610 spectrophotometer (Milton Roy) to measure the optical density of EBD in muscle. (2) We further intramuscularly injected CTX (10 uM, 10 ml/kg of body weight, Sigma-Aldrich) into burn-injured and sham control mice. At 12 hours post-injection, mice serum was collected for ELISA tests for the levels of LDH and CK-MB (Sigma-Aldrich) 15, 19, 29 .
Membrane repair assay in ex-vivo. FDB muscles were surgically intactly excised in a Tyrode solution.
FDB muscles were digested in Tyrode solution supplemented with type I collagenase (2 mg/ml), for 60 min at 37 °C with gentle rocking. After digestion, FDB muscles were further dissociated to single fibers by passing them through pipettes with small diameter. Single myofibers were plated onto plastic-bottomed dishes 
RT-PCR.
Trizol (Invitrogen, CA, USA) was used to isolate total RNA in C2C12 myotubules. RNA was used as a template for cDNA synthesis using Moloney Murine Leukemia Virus reverse transcriptase (Invitrogen, CA, USA). RT-PCR was executed using Taq polymerase and the following primers (Invitrogen, CA, USA): MG53 (forward, reverse) primers include: 5′-ACTGAGCATCTACTGCGAGC-3′ and 5′-ACGATGACCACGGTGAGAAC-3′; GAPDH (for ward, reverse) primers include: 5′ -CTGCGACCACCAACTGCT TAGC-3′ and 5′-CTTCACCACCTTCTTGATGTC-3′.
Immunohistochemistry. Gastrocnemius muscles were sectioned (10 μm thick) using a cryostat (CM1900, Leica, Wetzlar, Germany) at −20 °C. The sections were incubated with 2% H 2 O 2 in absolute methanol for 30 min to eliminate endogenous peroxidase activity, and then blocked with 1% bovine serum albumin (BSA) phosphate-buffered saline (PSA) containing 0.1% Triton X-100 for 60 min. The muscle sections were incubated at 4 °C for 12 h with antibodies to MG53 (1:200), followed by incubation with secondary antibodies. Diaminobenzidine (DAB) was detected and imaged by Axiovert 200 microscope (Zeiss).
Western blot analysis. The extracted proteins were separated using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to a polyvinylidene fluoride (PVDF) membrane. These membranes were incubated at 4 °C overnight with anti-MG53 (1:200), anti-PDI (1:500), anti-CHOP (1:200), anti-IRS1 (1:1000), anti-SOCS-1 (1:200), anti-SOCS-3 (1:1000) and GAPDH (1:5000) antibodies, followed by washes with Tris-Buffered Saline Tween (TBST) and incubation with appropriate secondary antibodies. Following washes with TBST, protein bands were detected using enhanced chemoluminescence ECL (Healthcare, Buckinghamshire, United Kingdom).
Immunofluorescent microscopy. C2C12 myotubes were cultured on coverslips, and then fixed in 3.7% paraformaldehyde solution for 10 min, permeabilised with 0.1% Triton X-100 in PBS for 30 min, and blocked in 2% BSA in PBS for 30 min. C2C12 myotubes monolayers were incubated with antibodies to SOCS-1 (1:1000), SOCS-3 (1:1000), IRS-1 (1:1000) for overnight at 4 °C, followed by incubation with secondary antibodies for 1 h at 37 °C. The cell nuclei were stained by DAPI (blue) at a concentration of 1.43 μM.
Biotin-switch assay. SNO-PDI was tested using the biotin-switch assay. Briefly, protein samples were added to a mix with 20 mM methylmethanethiosulfonate and 2.5% SDS in HEN buffer and were incubated at 50 °C for 1 h. Acetone were used to remove methylmethanethiosulfonate, then we used 1 mM ascorbate to reduce free thiols. The formed thiols were linked to the biotin-HPDP. The biotinylated proteins were pulled down, and SNO-PDI remaining in the precipitation was detected by western blotting.
PDI activity assay. The PDI activity was detected as described previously. Briefly C2C12 myotubes lysates were mixed with buffer (1 mM DTT, 30 μM insulin, and 3.0 mM sodium EDTA, in a buffer containing 100 mM sodium phosphate). Precipitation of insulin B chain was measured by an increase in absorbance at 650 nm.
